Skip to main content
Leopoldo Segal, MD, Pulmonology, New York, NY

Leopoldo Nicolas Segal MD

Critical Care Medicine, Pleural Disease


Assistant Professor, Medicine, New York University School of Medicine

Join to View Full Profile
  • 462 1st AveRm 7N24New York, NY 10016

  • Phone+1 212-263-6479

  • Fax+1 212-263-8442

Dr. Segal is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • NYU Grossman School of Medicine
    NYU Grossman School of MedicineFellowship, Pulmonary Disease and Critical Care Medicine, 2007 - 2010
  • Atlantic Health System/Overlook Medical Center
    Atlantic Health System/Overlook Medical CenterResidency, Internal Medicine, 2004 - 2007
  • Universidad Nacional de La Plata  Faculty of Medicine
    Universidad Nacional de La Plata Faculty of MedicineClass of 1999

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2007 - 2026
  • NJ State Medical License
    NJ State Medical License 2005 - 2009
  • Critical Care Medicine
    American Board of Internal Medicine Critical Care Medicine

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Translating Microbiome Futures  
    Leopoldo Segal, Martin Blaser, Nature
  • Airway Microbiota Is Associated with up-Regulation of the PI3K Pathway in Lung Cancer  
    Benjamin G Wu, Harvey Pass, William N Rom, Daniel H Sterman, Vivek Murthy, Martin J Blaser, Michael D Weiden, Leopoldo N Segal, ATS Journals

Press Mentions

  • Micronoma, NYU Partner to Develop Microbial Biomarkers of Lung Cancer
    Micronoma, NYU Partner to Develop Microbial Biomarkers of Lung CancerMay 19th, 2023
  • High Viral Load in Lungs Drives Fatal COVID-19
    High Viral Load in Lungs Drives Fatal COVID-19September 9th, 2021
  • Long-Term Mask Use May Contribute to Advanced Stage Lung Cancer, Study Finds
    Long-Term Mask Use May Contribute to Advanced Stage Lung Cancer, Study FindsSeptember 2nd, 2021
  • Join now to see all

Grant Support

  • Age related loss of immune resilience during response to severe respiratory viral infectionsNEW YORK UNIVERSITY SCHOOL OF MEDICINE2024–2029
  • Microbial and host biomarker development for detection and prognosis of early stage non-small cell lung cancerNEW YORK UNIVERSITY SCHOOL OF MEDICINE2023–2028
  • BIOREPOSITORY OPTIMIZATION AND USE FOR ENDOTYPING CRITICALLY ILL SARS-COV-2 INFECTED PATIENTSNEW YORK UNIVERSITY SCHOOL OF MEDICINE2022–2026
  • Local microbiota signatures of pro-tumor immunity and checkpoint inhibition susceptibility in lung cancerNEW YORK UNIVERSITY SCHOOL OF MEDICINE2020–2024
  • Local microbiota signatures of pro-tumor immunity and checkpoint inhibition susceptibility in lung cancerNEW YORK UNIVERSITY SCHOOL OF MEDICINE2020–2024

Other Languages

  • Spanish

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: